rs370378060

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001244008.2(KIF1A):​c.3094A>T​(p.Met1032Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,567,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1032I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

KIF1A
NM_001244008.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.813

Publications

0 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037021905).
BP6
Variant 2-240746147-T-A is Benign according to our data. Variant chr2-240746147-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 532874.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.3094A>T p.Met1032Leu missense_variant Exon 30 of 49 ENST00000498729.9 NP_001230937.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.3094A>T p.Met1032Leu missense_variant Exon 30 of 49 5 NM_001244008.2 ENSP00000438388.1

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152054
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000227
AC:
4
AN:
175828
AF XY:
0.0000212
show subpopulations
Gnomad AFR exome
AF:
0.000424
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000162
AC:
23
AN:
1415560
Hom.:
0
Cov.:
33
AF XY:
0.0000171
AC XY:
12
AN XY:
699922
show subpopulations
African (AFR)
AF:
0.000526
AC:
17
AN:
32344
American (AMR)
AF:
0.0000265
AC:
1
AN:
37778
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25354
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36984
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80340
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49422
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5726
European-Non Finnish (NFE)
AF:
9.18e-7
AC:
1
AN:
1088922
Other (OTH)
AF:
0.0000682
AC:
4
AN:
58690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152172
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41514
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67974
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000136
ESP6500AA
AF:
0.000498
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000169
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 23, 2017
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M931L variant (also known as c.2791A>T), located in coding exon 27 of the KIF1A gene, results from an A to T substitution at nucleotide position 2791. The methionine at codon 931 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jun 28, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Jul 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
17
DANN
Benign
0.86
DEOGEN2
Benign
0.16
T;.;.;.;.;.;.;T;.;.;.;.;.
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.88
.;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.037
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
-0.050
N;.;.;.;.;.;.;N;.;.;.;.;.
PhyloP100
0.81
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.4
.;N;N;.;.;.;.;.;.;.;.;.;N
REVEL
Benign
0.12
Sift
Benign
0.42
.;T;T;.;.;.;.;.;.;.;.;.;T
Sift4G
Benign
1.0
.;T;T;.;.;.;.;.;.;.;.;.;.
Polyphen
0.0010
B;.;.;.;.;.;.;B;.;.;.;.;B
Vest4
0.22, 0.17
MutPred
0.26
Gain of glycosylation at S934 (P = 0.1411);.;Gain of glycosylation at S934 (P = 0.1411);.;.;Gain of glycosylation at S934 (P = 0.1411);.;Gain of glycosylation at S934 (P = 0.1411);Gain of glycosylation at S934 (P = 0.1411);.;.;.;.;
MVP
0.22
MPC
0.40
ClinPred
0.054
T
GERP RS
3.2
PromoterAI
0.0074
Neutral
Varity_R
0.23
gMVP
0.44
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370378060; hg19: chr2-241685564; API